Navigation Links
Enhancing Survival Rate Of Lung Cancer Patients

Investigators in an international study found the survival rate of non-small-cell lung cancer patients after its removal // improved with cisplatin-based adjuvant chemotherapy. Cisplatin is an anti-neoplastic medication that interferes with the growth of cancer cells and slows their growth and spread in the body.

Researchers randomly assigned 1,867 patients to receive either three or four cycles of cisplatin-based chemotherapy or observation. In addition to cisplatin, the drug etoposide was given to about 56 percent of patients; the drug vinorelbine was given to about 26 percent of patients; vinblastine was given to 11 percent of patients, and vindesine was given to nearly 6 percent of patients. Of the 932 patients assigned to chemotherapy, nearly 73 percent received at least 240 milligrams of cisplatin per square meter of body-surface area.

Results of the study showed that after five years, patients assigned to chemotherapy had a significantly higher survival rate at 44.5 percent than those assigned to observation who had a 40.4 survival rate at five years. Patients assigned to chemotherapy also had a significantly higher disease-free survival rate at 39.4 percent than those assigned to observation with 34.3 percent.

Thus researchers say their results indicate that roughly 7,000 deaths from non-small-cell carcinoma would be averted annually with the use of adjuvant cisplatin-based chemotherapy.
'"/>




Page: 1

Related medicine news :

1. Enhancing Infants Immune System
2. Rescuing Injured Hearts by Enhancing Regeneration
3. Saudi Arabia for Enhancing Health Sector Ties with India
4. Elevate End- Of- Life Experience by Enhancing Quality of Hospice Care
5. Testosterone Cream – Ineffective in Enhancing Libido in Female Cancer Survivor
6. Long-Term Survival can be Predicted by a Simple Lung Test
7. Hepatitis G May Boost HIV Survival
8. Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy"
9. Longer Lung Cancer Survival
10. ICU Survival can be improved by Antibiotic use
11. Vasopressin Found To Boost Survival In Sudden Cardiac arrest
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: